Antibodies from Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas

MLA

Michael Lim, et al. Antibodies from Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.22458350.v1.

APA

Michael Lim, Drew M. Pardoll, Henry Brem, Charles G. Drake, Peter C. Burger, Janis M. Taube, Alessandro Olivi, Xiaobu Ye, Phuoc T. Tran, Betty M. Tyler, Allison M. Martin, Mary Sheu, Tomas Garzon-Muvdi, Sarah Harris-Bookman, Christopher M. Jackson, Dimitrios Mathios, Haiying Xu, Ada Tam, Eric W. Sankey, … Jennifer E. Kim. (2023). Antibodies from Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas. https://doi.org/10.1158/1078-0432.22458350.v1

Chicago

Michael Lim, Drew M. Pardoll, Henry Brem, Charles G. Drake, Peter C. Burger, Janis M. Taube, Alessandro Olivi, et al. 2023. “Antibodies from Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas,” March. doi:10.1158/1078-0432.22458350.v1.